The role of cyclin Y in normal and pathological cells

References

• Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 2013;140(15):3079–3093.
   PubMed Web of Science ®Google Scholar
• Child ES, Hendrychová T, McCague K, et al. A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding. Biochim Biophys Acta. 2010;1803(7):858–864.
   PubMed Web of Science ®Google Scholar
• Obaya AJ, Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci. 2002;59(1):126–142.
   PubMed Web of Science ®Google Scholar
• Wood DJ, Endicott JA. Structural insights into the functional diversity of the CDK–cyclin family. Open Biol. 2018;8(9):180112.
   PubMed Web of Science ®Google Scholar
• Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93–115.
   PubMed Web of Science ®Google Scholar
• Liu D, Finley RL. Cyclin Y is a novel conserved cyclin essential for development in drosophila. Genet. 2010;184(4):1025–1035.
   PubMed Web of Science ®Google Scholar
• Safran M, Rosen N, Twik M, et al. The GeneCards Suite. In: Abugessaisa I Kasukawa T editors. Practical Guide to Life Science Databases. Singapore: Springer Singapore; 2021pp. 27–56. cited 2022 Apr 28. InternetAvailable from. DOI:10.1007/978-981-16-5812-9_2
   Google Scholar
• Cho E, Kim D-H, Hur Y-N, et al. Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP. Sci Rep. 2015;5(1):12624.
   PubMedGoogle Scholar
• Jiang M, Gao Y, Yang T, et al. Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett. 2009;583(13):2171–2178.
   PubMed Web of Science ®Google Scholar
• Mikolcevic P, Sigl R, Rauch V, et al. Cyclin-Dependent Kinase 16/PCTAIRE kinase 1 is activated by Cyclin Y and is essential for spermatogenesis. Mol Cell Biol. 2012;32(4):868–879.
   PubMed Web of Science ®Google Scholar
• Shi K, Ru Q, Zhang C, et al. Cyclin Y modulates the proliferation, invasion, and metastasis of hepatocellular carcinoma cells. Med Sci Monit. 2018;24:1642–1653.
   PubMed Web of Science ®Google Scholar
• Joe I-S, Kim J-H, Kim H, et al. Cyclin Y-mediated transcript profiling reveals several important functional pathways regulated by Cyclin Y in hippocampal neurons. PLoS ONE. 2017;12(2):e0172547.
   PubMed Web of Science ®Google Scholar
• Pond KW, Doubrovinski K, Thorne CA. Wnt/β-catenin signaling in tissue self-organization. Genes. 2020;11(8):939.
   PubMed Web of Science ®Google Scholar
• Jung Y-S, Park J-I. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex. Exp Mol Med. 2020;52(2):183–191.
   PubMed Web of Science ®Google Scholar
• Zi Z, Zhang Z, Li Q, et al. Correction: cCNYL1, but not CCNY, cooperates with CDK16 to regulate spermatogenesis in mouse. PLoS Genet. 2019;15(3):e1008021.
   PubMed Web of Science ®Google Scholar
• An W, Zhang Z, Zeng L, et al. Cyclin Y is involved in the regulation of adipogenesis and lipid production. PLoS ONE. 2015;10(7):e0132721.
   PubMed Web of Science ®Google Scholar
• Sun T, Co NN, Wong N. PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma. Biochem Biophys Res Commun. 2014;449(1):163–168.
   PubMed Web of Science ®Google Scholar
• Wang X, Jia Y, Fei C, et al. Activation/proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5/6) Constitutive Phosphorylation. J Biol Chem. 2016;291(51):26427–26434.
   PubMed Web of Science ®Google Scholar
• Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–215.
   PubMed Web of Science ®Google Scholar
• Dohmen M, Krieg S, Agalaridis G, et al. AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy. Nat Commun. 2020;11(1):1032.
   PubMed Web of Science ®Google Scholar
• Vervoorts J, Neumann D, Lüscher B. The CCNY (cyclin Y)-CDK16 kinase complex: a new regulator of autophagy downstream of AMPK. Autophagy. 2020;16(9):1724–1726.
   PubMed Web of Science ®Google Scholar
• Gatica D, Klionsky DJ. New tricks of an old autophagy regulator: aMPK-dependent regulation of autophagy through CCNY (cyclin Y)-CDK16. Autophagy. 2020;16(6):973–974.
   PubMed Web of Science ®Google Scholar
• Hwang H, Hur Y-N, Sohn H, et al. Cyclin Y, a novel actin-binding protein, regulates spine plasticity through the cofilin-actin pathway. Prog Neurobiol. 2021;198:101915.
   PubMed Web of Science ®Google Scholar
• Ou C-Y, Poon VY, Maeder CI, et al. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell. 2010;141(5):846–858.
   PubMed Web of Science ®Google Scholar
• Hwang H, Seo J, Choi Y, et al. Ccny knockout mice display an enhanced susceptibility to kainic acid-induced epilepsy. Pharmacol Res. 2020;160:105100.
   PubMed Web of Science ®Google Scholar
• Kennell JA, MacDougald OA. Wnt signaling inhibits adipogenesis through β-catenin-dependent and -independent Mechanisms. J Biol Chem. 2005;280(25):24004–24010.
   PubMed Web of Science ®Google Scholar
• Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289(5481):950–953.
   PubMed Web of Science ®Google Scholar
• Molinas A, Heil S, Koch S. The candidate IBD risk gene CCNY is dispensable for intestinal epithelial homeostasis. Cells. 2021;10(9):2330.
   PubMed Web of Science ®Google Scholar
• Kyselova A, Siragusa M, Anthes J, et al. Cyclin Y is expressed in platelets and modulates integrin outside-in signaling. Int J Mol Sci. 2020;21(21):8239.
   PubMed Web of Science ®Google Scholar
• Chao DL, Sanchez CA, Galipeau PC, et al. Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with barrett’s esophagus: a long-term prospective study. Clin Cancer Res. 2008;14(21):6988–6995.
   PubMed Web of Science ®Google Scholar
• Casimiro MC, Crosariol M, Loro E, et al. Cyclins and cell cycle control in cancer and disease. Genes & Cancer. 2012;3(11–12):649–657.
   PubMedGoogle Scholar
• Liu D, Guest S, Finley RL. Why cyclin Y? a highly conserved cyclin with essential functions. Fly. 2010;4(4):278–282.
   PubMed Web of Science ®Google Scholar
• Davidson G, Niehrs C. Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol. 2010;20(8):453–460.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang Z, Wang J, et al. Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation. Oncol Res Featuring Preclinical Clin Cancer Ther. 2009;18(8):359–364.
   Google Scholar
• Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep. 2019;6(2):104–111.
   PubMedGoogle Scholar
• Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett. 2011;305(2):123–143.
   PubMed Web of Science ®Google Scholar
• Spiering D, Hodgson L. Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adhes Migr. 2011;5(2):170–180.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang X, Cheng H, et al. Cyclin Y binds and activates CDK4 to promote the G1/S phase transition in hepatocellular carcinoma cells via Rb signaling. Biochem Biophys Res Commun. 2020;533(4):1162–1169.
   PubMed Web of Science ®Google Scholar
• Hou J, Meng F, Chan LWC, et al. Circulating plasma microRNAs as diagnostic markers for NSCLC. Front Genet. 2016;7:193.
   PubMed Web of Science ®Google Scholar
• Ma L, Gu M, Teng Y, et al. Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients. OTT. 2019;12:921–932.
   Google Scholar
• Zhao X, Jiang M, Teng Y, et al. Cytoplasmic localization isoform of cyclin Y enhanced the metastatic ability of lung cancer via regulating tropomyosin 4. Front Cell Dev Biol. 2021;9:684819.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6):100773.
   PubMed Web of Science ®Google Scholar
• Derynck R, Weinberg RA. EMT and cancer: more than meets the eye. Dev cell. 2019;49(3):313–316.
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429–1437.
   PubMed Web of Science ®Google Scholar
• Recondo G, Che J, Jänne PA, et al. Targeting MET dysregulation in cancer. Cancer Discov. 2020;10(7):922–934.
   PubMed Web of Science ®Google Scholar
• Liu H, Shi H, Fan Q, et al. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway. Tumour Biol. 2016;37(8):10161–10175.
   PubMedGoogle Scholar
• Momenimovahed Z, Tiznobaik A, Taheri S, et al. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287–299.
   PubMed Web of Science ®Google Scholar
• Yan F, Wang X, Zhu M, et al. RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth. Oncol Rep. 2016;36(5):2793–2799.
   PubMed Web of Science ®Google Scholar
• Li X, Li J, Xu L, et al. CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1. J Exp Clin Cancer Res. 2022;41(1):149.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang L, Geng A, et al. CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression. Cell Rep. 2022;40(11):111331.
   PubMed Web of Science ®Google Scholar